Skip to main content
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1995 Jul;40(1):79–82. doi: 10.1111/j.1365-2125.1995.tb04539.x

A survey of the administration of drugs to young infants. The Alspac Survey Team. Avon Longitudinal Study of Pregnancy and Childhood.

N Hawkins 1, J Golding 1
PMCID: PMC1365032  PMID: 8527273

Abstract

Medication which is given to young infants during the first months of life, an important period of development, may have effects on development which would not be observed in adults receiving the same drugs. The aim of this study was to estimate the numbers of children receiving various types of medication, including both prescription and non-prescription drugs, during the first 6 months of life. Self-completion questionnaires were posted to mothers participating in the Avon Longitudinal Study of Pregnancy & Childhood (ALSPAC) when their children were 6 months of age. These questionnaires included enquiries about the administration of drugs to the study children. The study was based in the three Bristol-based health districts of Avon in the United Kingdom. The study population comprised of 6973 children born in the 12 month period between the 1st July 1991 and the 30th June 1992. The majority of mothers, 96%, reported that their children had received medication, excluding vaccines, during the first 6 months of life. 35% had been given drugs from four or more different classes. Paracetamol had been given to 84% of the children, antibiotics to 30%. In view of potential effects of drug exposure on long term development, it is important that drugs which are administered to children are carefully assessed to ensure that they are not harmful.

Full text

PDF
79

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bellinger D., Leviton A., Waternaux C., Needleman H., Rabinowitz M. Low-level lead exposure, social class, and infant development. Neurotoxicol Teratol. 1988 Nov-Dec;10(6):497–503. doi: 10.1016/0892-0362(88)90084-0. [DOI] [PubMed] [Google Scholar]
  2. Benesová O., Pavlík A. Perinatal treatment with glucocorticoids and the risk of maldevelopment of the brain. Neuropharmacology. 1989 Jan;28(1):89–97. doi: 10.1016/0028-3908(89)90073-7. [DOI] [PubMed] [Google Scholar]
  3. Golding J. Children of the nineties. A longitudinal study of pregnancy and childhood based on the population of Avon (ALSPAC). West Engl Med J. 1990 Sep;105(3):80–82. [PMC free article] [PubMed] [Google Scholar]
  4. Hanson J. W., Myrianthopoulos N. C., Harvey M. A., Smith D. W. Risks to the offspring of women treated with hydantoin anticonvulsants, with emphasis on the fetal hydantoin syndrome. J Pediatr. 1976 Oct;89(4):662–668. doi: 10.1016/s0022-3476(76)80414-3. [DOI] [PubMed] [Google Scholar]
  5. Huisjes H. J., Hadders-Algra M., Touwen B. C. Is clonidine a behavioural teratogen in the human? Early Hum Dev. 1986 Jul;14(1):43–48. doi: 10.1016/0378-3782(86)90168-4. [DOI] [PubMed] [Google Scholar]
  6. Streissguth A. P., Treder R. P., Barr H. M., Shepard T. H., Bleyer W. A., Sampson P. D., Martin D. C. Aspirin and acetaminophen use by pregnant women and subsequent child IQ and attention decrements. Teratology. 1987 Apr;35(2):211–219. doi: 10.1002/tera.1420350207. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES